Atom Investors LP Cti Biopharma Corp Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$5.36 - $7.43 $369,722 - $512,506	-68,978 Reduced 52.06%	63,512 $370,000
Q2 2022 Aug 15, 2022	SELL	$3.55 - $6.27 $196,307 - $346,718	-55,298 Reduced 29.45%	132,490 $791,000
Q1 2022 May 16, 2022	BUY	$1.9 - $5.23 $139,988 - $385,335	73,678 Added 64.57%	187,788 $877,000
Q4 2021 Feb 14, 2022	BUY	$1.44 - $2.86 $164,318 - $326,354	114,110 New	114,110 $283,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.